trihexyphenidyl has been researched along with orphenadrine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (78.57) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Marsden, CD | 1 |
| Parkenberg, H | 1 |
| di Costanzo, E; Schifano, F | 1 |
| Götestam, KG; Vågen, R | 1 |
| Bowers, MB; Roth, RH | 1 |
| Birket-Smith, E | 1 |
| Costall, B; Naylor, RJ | 1 |
| Clark, MS; Palfreyman, ES; Palfreyman, MG | 1 |
| Heikkila, RE; Orlansky, H | 1 |
| Andersen, PR; Gibbs, P; Kubinski, H | 1 |
| Ban, T; Hojo, M | 1 |
| Florio, V; Longo, VG | 1 |
| Hughes, RC; Polgar, JG; Walton, JN; Weightman, D | 1 |
| Fouks, L; Houssait, A; Lerno, M; Périvier, E | 1 |
| Burnett, GB; Creese, IC; Jolliff, LA; Prange, AJ; Synder, SH; Wilson, IC | 1 |
| Best, NR; Maguire, J; Pullen, GP | 1 |
| Berger, HJ; Buytenhuijs, EL; Cools, AR; Horstink, MW; Van Spaendonck, KP | 1 |
| Buhrich, N; Kevans, P; Weller, A | 1 |
| GILLINGHAM, FJ; KALYANARAMAN, S | 1 |
| TURNER, JW | 1 |
| STRANG, RR | 2 |
| DRAPER, IT; JOHNS, RJ | 1 |
2 review(s) available for trihexyphenidyl and orphenadrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advances in the management of parkinson's disease.
Topics: Amantadine; Anesthesia; Humans; Levodopa; Orphenadrine; Parasympatholytics; Parkinson Disease; Social Adjustment; Trihexyphenidyl | 1976 |
2 trial(s) available for trihexyphenidyl and orphenadrine
| Article | Year |
|---|---|
An experimental evaluation of the euphoric properties of antiparkinson drugs on psychotic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Euphoria; Female; Humans; Male; Middle Aged; Orphenadrine; Parkinson Disease, Secondary; Procyclidine; Psychotic Disorders; Pyrrolidines; Trihexyphenidyl | 1986 |
Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.
Topics: Dihydroxyphenylalanine; Drug Synergism; Drug Tolerance; Female; Humans; Male; Methods; Neurologic Manifestations; Orphenadrine; Parasympatholytics; Parkinson Disease; Salivation; Substance Withdrawal Syndrome; Time Factors; Tremor; Trihexyphenidyl | 1971 |
24 other study(ies) available for trihexyphenidyl and orphenadrine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
[Treatment of parkinsonism].
Topics: Amantadine; Benztropine; Biperiden; Humans; Levodopa; Orphenadrine; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1976 |
Excessive use of anticholinergic drugs in a sub-sample of Italian schizophrenics.
Topics: Adult; Biperiden; Female; Humans; Italy; Male; Middle Aged; Orphenadrine; Parasympatholytics; Patient Compliance; Procyclidine; Retrospective Studies; Sampling Studies; Schizophrenia; Trihexyphenidyl | 1991 |
Interaction of atropine-like drugs with dopamine-containing neurones in rat brain.
Topics: Animals; Atropine; Benztropine; Brain; Chlorpromazine; Dopamine; Homovanillic Acid; Male; Methyltyrosines; Neurons; Orphenadrine; Phenothiazines; Procyclidine; Rats; Time Factors; Trihexyphenidyl | 1972 |
Abnormal involuntary movements induced by anticholinergic therapy.
Topics: Aged; Biperiden; Dibenzazepines; Female; Humans; Mastication; Middle Aged; Movement Disorders; Orphenadrine; Parasympatholytics; Parkinson Disease; Phenothiazines; Procyclidine; Tremor; Trihexyphenidyl | 1974 |
The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Chlorpheniramine; Dopamine; Dopamine Antagonists; Drug Synergism; Histamine H1 Antagonists; Injections, Intraperitoneal; Male; Orphenadrine; Parasympatholytics; Parkinson Disease; Piperidines; Rats; Trihexyphenidyl | 1971 |
Effects of benapyrzine, a new antiparkinson drug, on dopamine uptake into corpus striatum.
Topics: Animals; Antiparkinson Agents; Benzilates; Catecholamines; Corpus Striatum; Dopamine; Ethylamines; Female; Hypothalamus; Imipramine; In Vitro Techniques; Kinetics; Orphenadrine; Propylamines; Rats; Scopolamine; Synaptosomes; Trihexyphenidyl; Tritium | 1974 |
An evaluation of various antiparkinsonian agents as releasing agents and uptake inhibitors for 3H-dopamine in slices of rat neostriatum.
Topics: Animals; Antiparkinson Agents; Benztropine; Catecholamines; Caudate Nucleus; Cerebral Cortex; Corpus Striatum; Diphenhydramine; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Orphenadrine; Putamen; Rats; Serotonin; Trihexyphenidyl; Tritium | 1974 |
Effects of neuropharmacological agents on in vitro formation of complexes between nucleic acids and proteins.
Topics: Animals; Benztropine; Cattle; Chlorpromazine; Codeine; Desipramine; DNA, Bacterial; Escherichia coli; Histones; Lysergic Acid Diethylamide; Morphine; Neostigmine; Nucleic Acids; Orphenadrine; Phenytoin; Protein Binding; Proteins; RNA, Bacterial; RNA, Ribosomal; Serum Albumin, Bovine; Sodium Dodecyl Sulfate; Trihexyphenidyl | 1974 |
A comparative study of the effects of anti-parkinson drugs on the oxotremorine-induced EEG and muscular activities.
Topics: Animals; Diphenhydramine; Drug Antagonism; Electroencephalography; Male; Muscle Tonus; Muscles; Orphenadrine; Parasympatholytics; Parkinson Disease; Propantheline; Propranolol; Pyrrolidinones; Rabbits; Scopolamine; Spasm; Tremorine; Trihexyphenidyl | 1971 |
Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
Topics: Amantadine; Amitriptyline; Animals; Antiparkinson Agents; Atropine; Behavior, Animal; Dihydroxyphenylalanine; Diphenhydramine; Drug Synergism; Imipramine; Mice; Orphenadrine; Parasympatholytics; Pargyline; Trihexyphenidyl | 1971 |
Parkinsonism and dopa.
Topics: Dihydroxyphenylalanine; Humans; New Zealand; Orphenadrine; Parkinson Disease; Parkinson Disease, Postencephalitic; Trihexyphenidyl | 1969 |
Antiparkinsonism drugs.
Topics: Antidepressive Agents; Atropine; Diphenhydramine; Humans; Orphenadrine; Parasympatholytics; Parkinson Disease; Promethazine; Scopolamine; Trihexyphenidyl | 1965 |
[Indications and modes of administration of fluphenazine enanthate].
Topics: Fluphenazine; Humans; Injections; Orphenadrine; Parasympathomimetics; Psychotic Disorders; Trihexyphenidyl; Tropanes | 1967 |
Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Benztropine; Dopamine; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Middle Aged; Orphenadrine; Parasympatholytics; Prolactin; Sex Factors; Thyrotropin; Trihexyphenidyl | 1980 |
Anticholinergic drug abuse: a common problem?
Topics: Adult; Biperiden; Female; Humans; Male; Middle Aged; Orphenadrine; Parasympatholytics; Schizophrenia; Substance-Related Disorders; Trihexyphenidyl | 1984 |
Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy.
Topics: Aged; Cognition; Female; Humans; Male; Middle Aged; Orphenadrine; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Trihexyphenidyl | 1993 |
Misuse of anticholinergic drugs by people with serious mental illness.
Topics: Adult; Benztropine; Female; Humans; Illicit Drugs; Male; Mental Disorders; Muscarinic Antagonists; New South Wales; Orphenadrine; Prevalence; Procyclidine; Substance-Related Disorders; Trihexyphenidyl | 2000 |
PARKINSON'S DISEASE.
Topics: Amitriptyline; Dextroamphetamine; Humans; Imipramine; Muscle Relaxants, Central; Neurosurgery; Orphenadrine; Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; Pathology; Stereotaxic Techniques; Trihexyphenidyl | 1963 |
PARKINSONISM: AETIOLOGY AND TREATMENT.
Topics: Carbon Monoxide Poisoning; Craniocerebral Trauma; Drug Therapy; Encephalitis; Intracranial Arteriosclerosis; Manganese; Neurosurgery; Neurosurgical Procedures; Orphenadrine; Parasympatholytics; Parkinsonian Disorders; Reserpine; Stereotaxic Techniques; Syphilis; Toxicology; Trihexyphenidyl | 1964 |
ORPHENADRINE IN THE TREATMENT OF PARKINSON'S DISEASE.
Topics: Biomedical Research; Geriatrics; Orphenadrine; Parkinson Disease; Parkinsonian Disorders; Pharmacology; Toxicology; Trihexyphenidyl | 1964 |
THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.
Topics: Atropine; Dextroamphetamine; Diphenhydramine; Drug Therapy; Geriatrics; Humans; Kinetics; Motor Skills; Movement Disorders; Orphenadrine; Parasympatholytics; Parkinsonian Disorders; Reaction Time; Trihexyphenidyl | 1964 |
A COMPARATIVE STUDY OF TRIHEXYPHENIDYL (ARTANE) AND ORPHENADRINE (DISIPAL) IN THE TREATMENT OF GERIATRIC PARKINSONISM.
Topics: Biomedical Research; Drug Therapy; Geriatrics; Orphenadrine; Parkinsonian Disorders; Toxicology; Trihexyphenidyl | 1965 |